Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer
DOI10.1080/01621459.2011.641416zbMATH Open1328.62601OpenAlexW2167371237WikidataQ36206859 ScholiaQ36206859MaRDI QIDQ4916481FDOQ4916481
Authors: Lu Wang, Xihong Lin, Randall E. Millikan, Peter F. Thall, Andrea Rotnitzky 
Publication date: 22 April 2013
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3433243
Recommendations
- Simultaneous inference for treatment regimes
- Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two‐stage stochastic dynamic treatment regime approach
- Comparison of treatment regimes with adjustment for auxiliary variables
- Sequential multiple assignment randomization trials with enrichment design
- SMART design, conduct, and analysis in oncology
causal inferenceefficiencyinverse probability weightinginformative dropoutsimultaneous confidence intervalsmarginal structural modelsoptimal regime
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Sequential statistical analysis (62L10)
Cites Work
- Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Bayesian inference for causal effects: The role of randomization
- Efficient design and inference for multistage randomized trials of individualized treatment policies
- Marginal Mean Models for Dynamic Regimes
- Optimal Dynamic Treatment Regimes
- Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data
- Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials
- Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
Cited In (21)
- A Bayesian decision framework for optimizing sequential combination antiretroviral therapy in people with HIV
- Simultaneous confidence bands for restricted logistic regression models
- Tree-based reinforcement learning for estimating optimal dynamic treatment regimes
- Estimating Tree-Based Dynamic Treatment Regimes Using Observational Data with Restricted Treatment Sequences
- Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II
- Interim monitoring of sequential multiple assignment randomized trials using partial information
- Adaptive contrast weighted learning for multi-stage multi-treatment decision-making
- A Bayesian machine learning approach for optimizing dynamic treatment regimes
- Stochastic tree search for estimating optimal dynamic treatment regimes
- Simultaneous confidence regions and weighted hypotheses on parameter arrays
- Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two‐stage stochastic dynamic treatment regime approach
- Optimal dynamic treatment regime estimation using information extraction from unstructured clinical text
- A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome
- Comparison of treatment regimes with adjustment for auxiliary variables
- Doubly-robust dynamic treatment regimen estimation via weighted least squares
- Ascertaining properties of weighting in the estimation of optimal treatment regimes under monotone missingness
- Step-adjusted tree-based reinforcement learning for evaluating nested dynamic treatment regimes using test-and-treat observational data
- Synthesizing studies for comparing different treatment sequences in clinical trials
- Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models
- Comment
- Treatment evaluation with multiple outcome periods under endogeneity and attrition
This page was built for publication: Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4916481)
